PROJECTION, not a promise: four quarters at the latest declared rate of $0.24. Boards raise, cut and suspend dividends; this table will be wrong whenever they do.
| Approx. period | Per share | Cumulative |
|---|---|---|
| 2023-07 | $0.24 | $0.24 |
| 2023-10 | $0.24 | $0.48 |
| 2023-12 | $0.24 | $0.72 |
| 2024-03 | $0.24 | $0.96 |
Assumes the latest declared quarterly rate holds — a projection, not a promise. Taxes and reinvestment not modeled (see the DRIP calculator for compounding).
| Fiscal quarter ending | Declared per share |
|---|---|
| 2023-03-31 | $0.24 |
| 2022-09-30 | $1.43 |
Every historical figure above is what Gyre Therapeutics, Inc.itself reported: per-share dividends declared each fiscal quarter. Declared-next comes from Nasdaq’s public data when the listing supports it; everything beyond that is the current rate carried forward and says so. Yield is trailing, computed against the last end-of-day close — a forward yield differs the moment the rate changes. Educational information, not investment advice.
What is GYRE's dividend yield?
Trailing twelve months, GYRE declared $1.67 per share; against its last close of $5.75 that is a 29.04% trailing yield. Forward yield differs when the rate changes.
Is GYRE's dividend growing?
Not enough filed history yet to compute a year-over-year comparison.
When is GYRE's next dividend?
No declared next payment is available from our sources; the projected schedule simply carries the latest quarterly rate forward and is labeled as a projection.
Keep going: GYRE workspace · DRIP calculator · dividend yield, defined · look up another payer